111 related articles for article (PubMed ID: 19167634)
1. The clinical and hemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST.
Sato Y; Miyamoto T; Taniguchi R; Nagao K; Matsuoka T; Fukuhara R; Kuwabara Y; Isoda K; Yamane K; Nishi K; Saijyo S; Fujiwara H; Takatsu Y
J Cardiol; 2009 Feb; 53(1):20-7. PubMed ID: 19167634
[TBL] [Abstract][Full Text] [Related]
2. [Bedside rapid measuring instrument--PATHFAST].
Kuwabara Y; Sato Y; Fujiwara H; Takatsu Y; Kita T
Nihon Rinsho; 2007 Apr; 65 Suppl 4():460-4. PubMed ID: 17508580
[No Abstract] [Full Text] [Related]
3. Influence of hemolysis on routine laboratory cardiac marker testing.
Daves M; Salvagno GL; Cemin R; Gelati M; Cervellin G; Guidi GC; Lippi G
Clin Lab; 2012; 58(3-4):333-6. PubMed ID: 22582509
[TBL] [Abstract][Full Text] [Related]
4. Method comparison of cardiac marker assays on PATHFAST, StratusCS, AxSYM, Immulite 2000, triage, elecsys and cardiac reader.
Peetz D; Schweigert R; Jachmann N; Post F; Schinzel H; Lackner KJ
Clin Lab; 2006; 52(11-12):605-14. PubMed ID: 17175892
[TBL] [Abstract][Full Text] [Related]
5. Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring high-sensitivity C-reactive protein, cardiac troponin I, heart-type fatty acid-binding protein, creatine kinase-MB, and myoglobin release.
Chowdhury UK; Malik V; Yadav R; Seth S; Ramakrishnan L; Kalaivani M; Reddy SM; Subramaniam GK; Govindappa R; Kakani M
J Thorac Cardiovasc Surg; 2008 May; 135(5):1110-9, 1119.e1-10. PubMed ID: 18455592
[TBL] [Abstract][Full Text] [Related]
6. The incremental benefit of a shortness-of-breath biomarker panel in emergency department patients with dyspnea.
Singer AJ; Thode HC; Green GB; Birkhahn R; Shapiro NI; Cairns C; Baumann BM; Aghababian R; Char D; Hollander JE
Acad Emerg Med; 2009 Jun; 16(6):488-94. PubMed ID: 19388909
[TBL] [Abstract][Full Text] [Related]
7. The role of existing and novel cardiac biomarkers for cardioprotection.
Gaze DC
Curr Opin Investig Drugs; 2007 Sep; 8(9):711-7. PubMed ID: 17729182
[TBL] [Abstract][Full Text] [Related]
8. [The use of cardiac markers bed test in acute coronary syndrome in emergency department].
Suppa M; Boccardo C; Cavicchi F; Contu E; Valeriani L; Colzi M; Giancaspro G; Scarpellini MG; Coppola A; Baldini E; Aguglia F
Clin Ter; 2011; 162(1):7-10. PubMed ID: 21448539
[TBL] [Abstract][Full Text] [Related]
9. [Quantitative analysis of serum troponin I and myoglobin in patients with acute myocardial infarction].
Xiao HG; Huang ZH; Liu HX; Lin YP
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):550-1. PubMed ID: 15897132
[TBL] [Abstract][Full Text] [Related]
10. The value of bedside cardiac multibiomarker assay in rapid and accurate diagnosis of acute coronary syndromes.
Dadkhah S; Sharain K; Sharain R; Kiabayan H; Foschi A; Zonia C; Huettl B; French S; Gray E; Venkatachalam S; Hegazy H; Aldinger G
Crit Pathw Cardiol; 2007 Jun; 6(2):76-84. PubMed ID: 17667870
[TBL] [Abstract][Full Text] [Related]
11. Point-of-care testing for cardiac markers in acute coronary syndromes and heart failure.
Lewandrowski K
Clin Lab Med; 2009 Sep; 29(3):561-71. PubMed ID: 19840688
[TBL] [Abstract][Full Text] [Related]
12. Elevation of myeloperoxidase in conjunction with cardiac-specific markers after marathon running.
Melanson SE; Green SM; Wood MJ; Neilan TG; Lewandrowski EL
Am J Clin Pathol; 2006 Dec; 126(6):888-93. PubMed ID: 17074690
[TBL] [Abstract][Full Text] [Related]
13. Authors' response to Apple editorial.
Kavsak PA; MacRae AR; Lustig V; Newman AM; Ko DT; Tu JV; Palomaki GE; Jaffe AS
Clin Chim Acta; 2007 May; 380(1-2):245-6. PubMed ID: 17328878
[No Abstract] [Full Text] [Related]
14. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarction.
Kavsak PA; MacRae AR; Newman AM; Lustig V; Palomaki GE; Ko DT; Tu JV; Jaffe AS
Clin Chim Acta; 2007 May; 380(1-2):213-6. PubMed ID: 17306781
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in acute cardiovascular disease.
Howie-Esquivel J; White M
J Cardiovasc Nurs; 2008; 23(2):124-31. PubMed ID: 18382255
[TBL] [Abstract][Full Text] [Related]
16. Standardization of cardiac markers.
Apple FS
Scand J Clin Lab Invest Suppl; 2005; 240():107-11. PubMed ID: 16112967
[TBL] [Abstract][Full Text] [Related]
17. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
[TBL] [Abstract][Full Text] [Related]
18. Frequency of clinically unsuspected myocardial injury at a children's hospital.
Lipshultz SE; Wong JC; Lipsitz SR; Simbre VC; Zareba KM; Galpechian V; Rifai N
Am Heart J; 2006 Apr; 151(4):916-22. PubMed ID: 16569563
[TBL] [Abstract][Full Text] [Related]
19. Cardiac troponin monitoring for detection of myocardial infarction: newer generation assays are here to stay.
Apple FS
Clin Chim Acta; 2007 May; 380(1-2):1-3; discussion 245-6. PubMed ID: 17306782
[No Abstract] [Full Text] [Related]
20. Evaluation of chest pain and heart failure in the emergency department: impact of multimarker strategies and B-type natriuretic peptide.
Gibler WB; Blomkalns AL; Collins SP
Rev Cardiovasc Med; 2003; 4 Suppl 4():S47-55. PubMed ID: 14564228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
